JP Morgan Chase
DMTX

JP Morgan Chase’s Dimension Therapeutics, Inc DMTX Stock Holding History

JP Morgan Chase’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10,713
Closed -$16K – 5430
2017
Q2 		$16K Sell
10,713
-13,273
-55% -$18K ﹤0.01% 4586
2017
Q1 		$42K Sell
23,986
-87,673
-79% -$233K ﹤0.01% 4576
2016
Q4 		$486K Buy
111,659
+23,434
+27% +$125K ﹤0.01% 3786
2016
Q3 		$705K Sell
88,225
-103,650
-54% -$749K ﹤0.01% 3283
2016
Q2 		$1.15M Sell
191,875
-47,125
-20% -$359K ﹤0.01% 3103
2016
Q1 		$1.87M Buy
239,000
+80,200
+51% +$632K ﹤0.01% 2738
2015
Q4 		$1.79M Buy
+158,800
New +$2.01M ﹤0.01% 2812

Other funds holding DMTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return